This company has shut down. Odyssey Therapeutics is no longer operating — its last tracked round was a Series A in 2021.
Explore the Startup GraveyardOdyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.
Odyssey Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
Odyssey Therapeutics's investors include HBM Healthcare Investments.
Odyssey Therapeutics is headquartered in San Francisco, United States.
Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.
Odyssey Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Odyssey Therapeutics — Funding & Investors." VCBacked, October 22, 2021, https://www.vcbacked.co/company/odyssey-therapeutics-san-francisco. Accessed October 21, 2026.
VCBacked. (2021). Odyssey Therapeutics — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/odyssey-therapeutics-san-francisco
{{cite web |title=Odyssey Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/odyssey-therapeutics-san-francisco |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated